 | • レポートコード：GIR-2104Z07918 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、イリノテカンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。イリノテカンの種類別市場規模（イリノテカン塩酸塩注射剤40mg、その他）、用途別市場規模（結腸がん、直腸がん）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・イリノテカンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：West-Ward Pharmaceuticals、Pfizer、Teva、Actiza Pharmaceutical、Getwell、Taj Pharma、Cipla、Salius ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：イリノテカン塩酸塩注射剤40mg、その他 ・用途別分析2016年-2026年：結腸がん、直腸がん ・イリノテカンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・イリノテカンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・イリノテカンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・イリノテカンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・イリノテカンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Irinotecan market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Irinotecan size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Irinotecan market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Irinotecan market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Irinotecan Hydrochloride Injection 40mg
Other
Market segment by Application can be divided into
Colon Cancer
Rectal Cancer
The key market players for global Irinotecan market are listed below:
West-Ward Pharmaceuticals
Pfizer
Teva
Actiza Pharmaceutical
Getwell
Taj Pharma
Cipla
Salius
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Irinotecan Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Irinotecan Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Irinotecan Hydrochloride Injection 40mg
1.2.3 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Irinotecan Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Colon Cancer
1.3.3 Rectal Cancer
1.4 Global Irinotecan Market Size & Forecast
1.4.1 Global Irinotecan Sales in Value (2016-2026))
1.4.2 Global Irinotecan Sales in Volume (2016-2026)
1.4.3 Global Irinotecan Price by Type (2016-2026) & (USD/Kg)
1.5 Global Irinotecan Production Capacity Analysis
1.5.1 Global Irinotecan Total Production Capacity (2016-2026)
1.5.2 Global Irinotecan Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Irinotecan Market Drivers
1.6.2 Irinotecan Market Restraints
1.6.3 Irinotecan Trends Analysis
2 Manufacturers Profiles
2.1 West-Ward Pharmaceuticals
2.1.1 West-Ward Pharmaceuticals Details
2.1.2 West-Ward Pharmaceuticals Major Business
2.1.3 West-Ward Pharmaceuticals Irinotecan Product and Services
2.1.4 West-Ward Pharmaceuticals Irinotecan Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Irinotecan Product and Services
2.2.4 Pfizer Irinotecan Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Teva
2.3.1 Teva Details
2.3.2 Teva Major Business
2.3.3 Teva Irinotecan Product and Services
2.3.4 Teva Irinotecan Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Actiza Pharmaceutical
2.4.1 Actiza Pharmaceutical Details
2.4.2 Actiza Pharmaceutical Major Business
2.4.3 Actiza Pharmaceutical Irinotecan Product and Services
2.4.4 Actiza Pharmaceutical Irinotecan Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Getwell
2.5.1 Getwell Details
2.5.2 Getwell Major Business
2.5.3 Getwell Irinotecan Product and Services
2.5.4 Getwell Irinotecan Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Taj Pharma
2.6.1 Taj Pharma Details
2.6.2 Taj Pharma Major Business
2.6.3 Taj Pharma Irinotecan Product and Services
2.6.4 Taj Pharma Irinotecan Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Cipla
2.7.1 Cipla Details
2.7.2 Cipla Major Business
2.7.3 Cipla Irinotecan Product and Services
2.7.4 Cipla Irinotecan Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Salius
2.8.1 Salius Details
2.8.2 Salius Major Business
2.8.3 Salius Irinotecan Product and Services
2.8.4 Salius Irinotecan Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Irinotecan Sales by Manufacturer
3.1 Global Irinotecan Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Irinotecan Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Irinotecan
3.4 Market Concentration Rate
3.4.1 Top 3 Irinotecan Manufacturer Market Share
3.4.2 Top 6 Irinotecan Manufacturer Market Share
3.5 Global Irinotecan Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Irinotecan Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Irinotecan Market Size by Region
4.1.1 Global Irinotecan Sales in Volume by Region (2016-2026)
4.1.2 Global Irinotecan Revenue by Region (2016-2026)
4.2 North America Irinotecan Revenue (2016-2026)
4.3 Europe Irinotecan Revenue (2016-2026)
4.4 Asia-Pacific Irinotecan Revenue (2016-2026)
4.5 South America Irinotecan Revenue (2016-2026)
4.6 Middle East and Africa Irinotecan Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Irinotecan Sales in Volume by Type (2016-2026)
5.2 Global Irinotecan Revenue by Type (2016-2026)
5.3 Global Irinotecan Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Irinotecan Sales in Volume by Application (2016-2026)
6.2 Global Irinotecan Revenue by Application (2016-2026)
6.3 Global Irinotecan Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Irinotecan Sales by Type (2016-2026)
7.2 North America Irinotecan Sales by Application (2016-2026)
7.3 North America Irinotecan Market Size by Country
7.3.1 North America Irinotecan Sales in Volume by Country (2016-2026)
7.3.2 North America Irinotecan Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Irinotecan Sales by Type (2016-2026)
8.2 Europe Irinotecan Sales by Application (2016-2026)
8.3 Europe Irinotecan Market Size by Country
8.3.1 Europe Irinotecan Sales in Volume by Country (2016-2026)
8.3.2 Europe Irinotecan Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Irinotecan Sales by Type (2016-2026)
9.2 Asia-Pacific Irinotecan Sales by Application (2016-2026)
9.3 Asia-Pacific Irinotecan Market Size by Region
9.3.1 Asia-Pacific Irinotecan Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Irinotecan Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Irinotecan Sales by Type (2016-2026)
10.2 South America Irinotecan Sales by Application (2016-2026)
10.3 South America Irinotecan Market Size by Country
10.3.1 South America Irinotecan Sales in Volume by Country (2016-2026)
10.3.2 South America Irinotecan Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Irinotecan Sales by Type (2016-2026)
11.2 Middle East & Africa Irinotecan Sales by Application (2016-2026)
11.3 Middle East & Africa Irinotecan Market Size by Country
11.3.1 Middle East & Africa Irinotecan Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Irinotecan Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Irinotecan Typical Distributors
12.3 Irinotecan Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Irinotecan Revenue by Type, (USD Million), 2021-2026
Table 2. Global Irinotecan Revenue by Application, (USD Million), 2021-2026
Table 3. West-Ward Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 4. West-Ward Pharmaceuticals Major Business
Table 5. West-Ward Pharmaceuticals Irinotecan Product and Services
Table 6. West-Ward Pharmaceuticals Irinotecan Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Major Business
Table 9. Pfizer Irinotecan Product and Services
Table 10. Pfizer Irinotecan Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Teva Basic Information, Manufacturing Base and Competitors
Table 12. Teva Major Business
Table 13. Teva Irinotecan Product and Services
Table 14. Teva Irinotecan Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Actiza Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 16. Actiza Pharmaceutical Major Business
Table 17. Actiza Pharmaceutical Irinotecan Product and Services
Table 18. Actiza Pharmaceutical Irinotecan Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Getwell Basic Information, Manufacturing Base and Competitors
Table 20. Getwell Major Business
Table 21. Getwell Irinotecan Product and Services
Table 22. Getwell Irinotecan Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Taj Pharma Basic Information, Manufacturing Base and Competitors
Table 24. Taj Pharma Major Business
Table 25. Taj Pharma Irinotecan Product and Services
Table 26. Taj Pharma Irinotecan Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Cipla Basic Information, Manufacturing Base and Competitors
Table 28. Cipla Major Business
Table 29. Cipla Irinotecan Product and Services
Table 30. Cipla Irinotecan Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Salius Basic Information, Manufacturing Base and Competitors
Table 32. Salius Major Business
Table 33. Salius Irinotecan Product and Services
Table 34. Salius Irinotecan Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Global Irinotecan Sales by Manufacturer (2019-2021e) & (MT)
Table 36. Global Irinotecan Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 37. Market Position of Manufacturers in Irinotecan, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 38. Global Irinotecan Production Capacity by Company, (MT): 2020 VS 2021
Table 39. Head Office and Irinotecan Production Site of Key Manufacturer
Table 40. Global Irinotecan Sales by Region (2016-2021e) & (MT)
Table 41. Global Irinotecan Sales by Region (2021-2026) & (MT)
Table 42. Global Irinotecan Revenue by Region (2016-2021e) & (USD Million)
Table 43. Global Irinotecan Revenue by Region (2021-2026) & (USD Million)
Table 44. Global Irinotecan Sales by Type (2016-2021e) & (MT)
Table 45. Global Irinotecan Sales by Type (2021-2026) & (MT)
Table 46. Global Irinotecan Revenue by Type (2016-2021e) & (USD Million)
Table 47. Global Irinotecan Revenue by Type (2021-2026) & (USD Million)
Table 48. Global Irinotecan Price by Type (2016-2021e) & (USD/Kg)
Table 49. Global Irinotecan Price by Type (2021-2026) & (USD/Kg)
Table 50. Global Irinotecan Sales by Application (2016-2021e) & (MT)
Table 51. Global Irinotecan Sales by Application (2021-2026) & (MT)
Table 52. Global Irinotecan Revenue by Application (2016-2021e) & (USD Million)
Table 53. Global Irinotecan Revenue by Application (2021-2026) & (USD Million)
Table 54. Global Irinotecan Price by Application (2016-2021e) & (USD/Kg)
Table 55. Global Irinotecan Price by Application (2021-2026) & (USD/Kg)
Table 56. North America Irinotecan Sales by Country (2016-2021e) & (MT)
Table 57. North America Irinotecan Sales by Country (2021-2026) & (MT)
Table 58. North America Irinotecan Revenue by Country (2016-2021e) & (USD Million)
Table 59. North America Irinotecan Revenue by Country (2021-2026) & (USD Million)
Table 60. North America Irinotecan Sales by Type (2016-2021e) & (MT)
Table 61. North America Irinotecan Sales by Type (2021-2026) & (MT)
Table 62. North America Irinotecan Sales by Application (2016-2021e) & (MT)
Table 63. North America Irinotecan Sales by Application (2021-2026) & (MT)
Table 64. Europe Irinotecan Sales by Country (2016-2021e) & (MT)
Table 65. Europe Irinotecan Sales by Country (2021-2026) & (MT)
Table 66. Europe Irinotecan Revenue by Country (2016-2021e) & (USD Million)
Table 67. Europe Irinotecan Revenue by Country (2021-2026) & (USD Million)
Table 68. Europe Irinotecan Sales by Type (2016-2021e) & (MT)
Table 69. Europe Irinotecan Sales by Type (2021-2026) & (MT)
Table 70. Europe Irinotecan Sales by Application (2016-2021e) & (MT)
Table 71. Europe Irinotecan Sales by Application (2021-2026) & (MT)
Table 72. Asia-Pacific Irinotecan Sales by Region (2016-2021e) & (MT)
Table 73. Asia-Pacific Irinotecan Sales by Region (2021-2026) & (MT)
Table 74. Asia-Pacific Irinotecan Revenue by Region (2016-2021e) & (USD Million)
Table 75. Asia-Pacific Irinotecan Revenue by Region (2021-2026) & (USD Million)
Table 76. Asia-Pacific Irinotecan Sales by Type (2016-2021e) & (MT)
Table 77. Asia-Pacific Irinotecan Sales by Type (2021-2026) & (MT)
Table 78. Asia-Pacific Irinotecan Sales by Application (2016-2021e) & (MT)
Table 79. Asia-Pacific Irinotecan Sales by Application (2021-2026) & (MT)
Table 80. South America Irinotecan Sales by Country (2016-2021e) & (MT)
Table 81. South America Irinotecan Sales by Country (2021-2026) & (MT)
Table 82. South America Irinotecan Revenue by Country (2016-2021e) & (USD Million)
Table 83. South America Irinotecan Revenue by Country (2021-2026) & (USD Million)
Table 84. South America Irinotecan Sales by Type (2016-2021e) & (MT)
Table 85. South America Irinotecan Sales by Type (2021-2026) & (MT)
Table 86. South America Irinotecan Sales by Application (2016-2021e) & (MT)
Table 87. South America Irinotecan Sales by Application (2021-2026) & (MT)
Table 88. Middle East & Africa Irinotecan Sales by Country (2016-2021e) & (MT)
Table 89. Middle East & Africa Irinotecan Sales by Country (2021-2026) & (MT)
Table 90. Middle East & Africa Irinotecan Revenue by Country (2016-2021e) & (USD Million)
Table 91. Middle East & Africa Irinotecan Revenue by Country (2021-2026) & (USD Million)
Table 92. Middle East & Africa Irinotecan Sales by Type (2016-2021e) & (MT)
Table 93. Middle East & Africa Irinotecan Sales by Type (2021-2026) & (MT)
Table 94. Middle East & Africa Irinotecan Sales by Application (2016-2021e) & (MT)
Table 95. Middle East & Africa Irinotecan Sales by Application (2021-2026) & (MT)
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Irinotecan Typical Distributors
Table 99. Irinotecan Typical Customers
List of Figures
Figure 1. Irinotecan Picture
Figure 2. Global Irinotecan Sales Market Share by Type in 2020
Figure 3. Irinotecan Hydrochloride Injection 40mg
Figure 4. Other
Figure 5. Global Irinotecan Sales Market Share by Application in 2020
Figure 6. Colon Cancer
Figure 7. Rectal Cancer
Figure 8. Global Irinotecan Market Size, (USD Million) & (MT): 2020 VS 2021 VS 2026
Figure 9. Global Irinotecan Market Size and Forecast (2016-2026) & (USD Million)
Figure 10. United States Irinotecan Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 11. Canada Irinotecan Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Mexico Irinotecan Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Germany Irinotecan Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. France Irinotecan Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. United Kingdom Irinotecan Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Russia Irinotecan Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Italy Irinotecan Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. China Irinotecan Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Japan Irinotecan Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Korea Irinotecan Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. India Irinotecan Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Southeast Asia Irinotecan Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Australia Irinotecan Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Brazil Irinotecan Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Egypt Irinotecan Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Saudi Arabia Irinotecan Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. South Africa Irinotecan Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Turkey Irinotecan Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Global Irinotecan Sales (2016-2026) & (MT)
Figure 30. Global Irinotecan Production Capacity (2016-2026) & (MT)
Figure 31. Global Irinotecan Production Capacity by Geographic Region: 2020 VS 2021
Figure 32. Irinotecan Market Drivers
Figure 33. Irinotecan Market Restraints
Figure 34. Irinotecan Market Trends
Figure 35. Global Irinotecan Sales Market Share by Manufacturer in 2020
Figure 36. Global Irinotecan Revenue Market Share by Manufacturer in 2020
Figure 37. Irinotecan Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 38. Top 3 Irinotecan Manufacturer (Revenue) Market Share in 2020
Figure 39. Top 6 Irinotecan Manufacturer (Revenue) Market Share in 2020
Figure 40. Global Irinotecan Sales Market Share by Region (2016-2026)
Figure 41. Global Irinotecan Revenue Market Share by Region (2016-2026)
Figure 42. North America Irinotecan Revenue (2016-2026) & (USD Million)
Figure 43. Europe Irinotecan Revenue (2016-2026) & (USD Million)
Figure 44. Asia-Pacific Irinotecan Revenue (2016-2026) & (USD Million)
Figure 45. South America Irinotecan Revenue (2016-2026) & (USD Million)
Figure 46. Middle East & Africa Irinotecan Revenue (2016-2026) & (USD Million)
Figure 47. Global Irinotecan Sales Market Share by Type (2016-2026)
Figure 48. Global Irinotecan Revenue Market Share by Type (2016-2026)
Figure 49. Global Irinotecan Price by Type (2016-2026) & (USD/Kg)
Figure 50. Global Irinotecan Sales Market Share by Application (2016-2026)
Figure 51. Global Irinotecan Revenue Market Share by Application (2016-2026)
Figure 52. Global Irinotecan Price by Application (2016-2026) & (USD/Kg)
Figure 53. North America Irinotecan Sales Market Share by Country (2016-2026)
Figure 54. North America Irinotecan Revenue Market Share by Country (2016-2026)
Figure 55. North America Irinotecan Sales Market Share by Type (2016-2026)
Figure 56. North America Irinotecan Sales Market Share by Application (2016-2026)
Figure 57. Europe Irinotecan Sales Market Share by Country (2016-2026)
Figure 58. Europe Irinotecan Revenue Market Share by Country (2016-2026)
Figure 59. Europe Irinotecan Sales Market Share by Type (2016-2026)
Figure 60. Europe Irinotecan Sales Market Share by Application (2016-2026)
Figure 61. Asia-Pacific Irinotecan Sales Market Share by Region (2016-2026)
Figure 62. Asia-Pacific Irinotecan Revenue Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Irinotecan Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Irinotecan Sales Market Share by Application (2016-2026)
Figure 65. South America Irinotecan Sales Market Share by Country (2016-2026)
Figure 66. South America Irinotecan Revenue Market Share by Country (2016-2026)
Figure 67. South America Irinotecan Sales Market Share by Type (2016-2026)
Figure 68. South America Irinotecan Sales Market Share by Application (2016-2026)
Figure 69. Middle East & Africa Irinotecan Sales Market Share by Country (2016-2026)
Figure 70. Middle East & Africa Irinotecan Revenue Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Irinotecan Sales Market Share by Type (2016-2026)
Figure 72. Middle East & Africa Irinotecan Sales Market Share by Application (2016-2026)
Figure 73. Sales Channel: Direct Channel vs Indirect Channel
Figure 74. Methodology
Figure 75. Research Process and Data Source
世界の結腸がん市場規模・現状・予測（2021年-2027年） Colon cancer is the cancer of large intestine which form the lower part of the digestive system. The disease usually begins with a small, benign clusters of cells known as adenomatous polyps. If left untreated, these polyps may result into colon cancer. Therefore, regular screening for polyps throug…- 世界の結腸・直腸がん市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Colon & Rectal Carcinoma Market The global Colon & Rectal Carcinoma market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the …
- 世界の植物性抗がん剤市場 2021：企業別、地域別、種類・用途別 The Plant Sources Anti Cancer Agents market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…
- 世界の腎芽腫治療市場規模・現状・予測（2021年-2027年） Nephroblastoma is a cancer of the kidneys that typically occurs in children, rarely in adults. Approximately 500 cases are diagnosed in the U.S. annually. The majority (75%) occurs in otherwise normal children; a minority (25%) is associated with other developmental abnormalities. It is highly respo…
- 世界の腎芽腫治療市場規模・現状・予測（2021年-2027年） Nephroblastoma is a cancer of the kidneys that typically occurs in children, rarely in adults. Approximately 500 cases are diagnosed in the U.S. annually. The majority (75%) occurs in otherwise normal children; a minority (25%) is associated with other developmental abnormalities. It is highly respo…